Exane BNP Paribas Downgrades Qorvo to Neutral, Announces $80 Price Target
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas has downgraded Qorvo from Outperform to Neutral, setting a price target of $80.
October 30, 2024 | 10:12 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Exane BNP Paribas has downgraded Qorvo from Outperform to Neutral, with a new price target of $80.
The downgrade from Outperform to Neutral by Exane BNP Paribas suggests a less optimistic view on Qorvo's future performance. The new price target of $80 indicates a potential downside from current levels, which could lead to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100